No Detail Found!

The detection of YMDD mutation of hepatitis B virus by allele-specific PCR and a cross-contamination proofed device.

Author(s)
Wanchuan Zhuang Department of Hematology, Lianyungang Second People’s Hospital (Lianyungang Hospital affiliated to Bengbu Medical College, Lianyungang, China
Ning Sha Department of Pediatrics, Huai’an Second People’s Hospital Affiliated to Xuzhou Medical College, Huai’an, China
Chun Lyu Department of Hepatology, Huai`an Fourth People`s Hospital, Huai’an, China
Jiaxin Li Department of Pediatrics, Huai`an First People’s Hospital, Nanjing Medical University, Huai’an, China
Abstract
Lamivudine (LAM) is commonly used to treat Hepatitis B virus (HBV) infection, but its use frequently induces drug resistance. Therefore, rapid and correct detection of drug-resistant HBV is important for effective treatment of HBV infection. In this study, we aimed to develop a novel, simple, and user-friendly method for the detection of LAM resistant HBV. Samples were collected from 60 HBV infected patients for the analysis by allele-specific polymerase chain reaction (AS-PCR), nucleic acid detection strip (NADS) and a cross-contamination proofed device. HBV YMDD mutations were detected by AS-PCR, restriction fragment length polymorphism (RFLP) and DNA sequencing. A 91.7% concordance between all three methods was obtained. Compared to sequencing and RFLP, AS-PCR detected more samples with mutant variants and was more sensitive. This novel method had a detection limit of approximately 103 copies/ml and detected a variant of only 5% of total HBV population. In conclusion, we develop a new assay which could be useful for the detection of HBV LAM resistance, especially in resource-poor settings.
Publication Details
Page(s) 1311-1314
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 28, Issue: 4, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

90

Views